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Abstract
There is compelling evidence to support the idea that autophagy has a protective function in neurons and its disruption
results in neurodegenerative disorders. Neuronal damage is well-documented in the brains of HIV-infected individuals, and
evidence of inflammation, oxidative stress, damage to synaptic and dendritic structures, and neuronal loss are present in the
brains of those with HIV-associated dementia. We investigated the role of autophagy in microglia-induced neurotoxicity in
primary rodent neurons, primate and human models. We demonstrate here that products of simian immunodeficiency virus
(SIV)-infected microglia inhibit neuronal autophagy, resulting in decreased neuronal survival. Quantitative analysis of
autophagy vacuole numbers in rat primary neurons revealed a striking loss from the processes. Assessment of multiple
biochemical markers of autophagic activity confirmed the inhibition of autophagy in neurons. Importantly, autophagy could
be induced in neurons through rapamycin treatment, and such treatment conferred significant protection to neurons. Two
major mediators of HIV-induced neurotoxicity, tumor necrosis factor-a and glutamate, had similar effects on reducing
autophagy in neurons. The mRNA level of p62 was increased in the brain in SIV encephalitis and as well as in brains from
individuals with HIV dementia, and abnormal neuronal p62 dot structures immunoreactivity was present and had a similar
pattern with abnormal ubiquitinylated proteins. Taken together, these results identify that induction of deficits in
autophagy is a significant mechanism for neurodegenerative processes that arise from glial, as opposed to neuronal,
sources, and that the maintenance of autophagy may have a pivotal role in neuroprotection in the setting of HIV infection.
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Introduction
Macroautophagy (referred here as autophagy) is a highly
inducible mechanism upon stress or injury in cells, in which a
small proportion of cytoplasm, including organelles, is engulfed
within double membrane vacuoles, known as autophagosomes or
autophagy vacuoles (AV), and then degraded by fusion with
lysosomes [1,2]. In addition to this inductive component,
constitutive autophagy has been found to be an indispensable
mechanism in terminally-differentiated cells such as neurons in
order clear up damaged long-lived nuclear and cytosolic proteins or
organelles. Autophagy is especially important where the ubiquitin-
proteasome apparatus is inefficient because of large molecule size
or its unselectively [3–5].
To date, several autophagy related genes (Atg) and their respective
proteins are known to directly regulate the formation of AV in
mammalian cells [2,6]. Among these proteins, it is known that the
covalently-bound complex of Atg12-Atg5 regulates the elongation of
AV isolation membrane known as phagophore [7,8]. In addition,
Atg12-Atg5 is an ubiquitin E3-like enzyme that conjugates the
microtubule-associated protein 1 light chain 3 (LC3, also known as
Atg8) to phosphatydilethanolamine, known as the conversion of
LC3-I to LC3-II [9,10]. LC3-II binds to the membrane of AV and
regulates their formation in cells. To date, LC3-II is the best
identified mammalian protein species that specifically associates with
AV membranes [10].
Recent studies have demonstrated that the suppression of
constitutive autophagy in neurons results in severe neurodegener-
ative disorders [1,5]. The selective genetic ablation of Atg5 or Atg7
in neurons leads to motor and behavioral deficits associated with
neuronal loss in the hippocampus, cerebral and cerebellar cortices
[1,5,11,12]. This clinical pathology observed in neuron-specific
autophagy-deficient mice parallels findings in patients with
neurodegenerative disorders [1]. These experiments clearly
demonstrate that autophagy is constitutively active in neurons
and is required for neuronal survival. In addition, the genetic
disruption of autophagy greatly impaired the degradation of
ubiquitin-protein aggregates, resulting in an accumulation of
ubiquitinated proteins in neurons [11,12]. Generally, short-lived
proteins are degraded via the ubiquitin-proteasome pathway, but
when there is proteasome dysfunction, autophagy can can serve to
degrade these proteins, as it does constitutively for the long lived
proteins [4].
Interestingly, the LC3-binding protein p62 (also known as
sequestosome 1), was initially identified as a protein that is induced
as a response to the oxygen radical stress or to the inhibition of
proteasomal activity [13–15]. Indeed, recent work has shown that
p62 couples polyubiquitinated protein aggregates to the autophagy
machinery via LC3, and facilitates the clearance of aggregates
resulting reduced toxicity [16,17]. Thus, in addition to LC3, p62
can also be employed as an autophagic marker as it is degraded by
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inhibition of autophagy and increased levels of p62 [16–19].
HIV- or Simian Immunodeficiency Virus (SIV)-associated
central nervous system (CNS) disease is an acquired form of
neurodegeneration resulting from the production of molecules
from activated and infected macrophages/microglia in the brain
[20,21]. Such non-neuronal sources of neurodegeneration,
referred to as non-cell autonomous neurodegenerative processes
are becoming increasing recognized to extend beyond infectious
diseases and may initiate and/or contribute to the progression of a
variety of neurodegenerative disorders [22]. Neuronal damage is
well-documented in the brains of HIV-infected individuals, and
evidence of inflammation, oxidative stress, damage to synaptic and
dendritic structures, and neuronal loss are present in the brains of
those with HIV-associated dementia (HAD) [23–26]. Intriguingly,
ubiquitin protein deposits are abundant in neurons in those with
HAD [27].
Using the well-characterized neurodegenerative activity of
products of SIV- or HIV-infected myeloid cells on neurons
[28,29], we investigated the role of autophagy in neurodegener-
ation in individual neurons primary rat cortical cultures. We
evaluated the number and location of AV using a high sensitivity
approach consisting of a combination of confocal microscopy and
three-dimensional reconstruction imaging software. Primary
neurons, expressing LC3 marked by green fluorescent protein
(GFP), were assessed for the presence and number of AV (as
marked by GFP-LC3) in both soma and processes. Images were
acquired and analyzed from neurons exposed to the supernatant of
SIV-infected microglia, derived from primary cultures of microglia
from animals with SIV encephalitis (SIVE). We then confirmed
the imaging results with the use of diverse biochemical markers
and chemical modifiers of autophagy, revealing the ability of glial
products to inhibit autophagy and decrease neuronal survival.
Changes in p62 mRNA levels, determined in a primate model
(SIVE and uninfected brains) and neuronal p62 protein distribu-
tion and content, detected by immunohistochemistry in monkey
brain tissues and HAD brains, support the in vivo relevance of these
findings.
Results
Three-dimensional modeling of primary neurons for AV
quantification
Although there are indications that autophagy is active in
developing primary neuronal cultures [3,29], techniques for
detecting autophagy in neurons have to date been qualitative.
As a first objective we established a method to quantitatively
determine the number of AV in primary neuronal cultures, both in
the soma and processes. Primary neuronal cultures were
transfected with GFP-LC3 to allow visualization of AV. Condi-
tions of low neuronal transfection efficiency (,2%) were used in
order to observe the soma and processes of single GFP-LC3
expressing neurons within the matrix of other neurons. To
quantify the spatial and temporal distribution of AV we acquired
confocal z-stacks for transfected neurons (Figures 1A–1J, 0.2 mm
step size, approximately 150 images acquired per cell). From these
data sets we were able to determine the 3D structure of the soma
and processes, as well as the number and distribution of GFP-
LC3-labelled AV (Figures 1K–1O). This imaging approach
allowed for the quantitative investigation of AV content and
localization in different conditions in order to understand their
potential changes in our in vitro model of SIV microglia
supernatant inducing neuronal cell death.
Microglia supernatant from SIV-infected rhesus monkeys
inhibits the generation of AV in primary neurons in a
rapamycin-reversible manner
Subsequently, to examine the role of autophagy in SIV
mediated neuronal cell death, we treated GFP-LC3-transfected
primary rat neurons, as described above, with supernatants from
microglia/macrophages of SIV-infected or uninfected monkeys
and determined the total number of AV. Separate monkey
microglia cultures were derived from cultures from infected and
uninfected animals, and the culture supernatants then subjected to
ultrafiltration to isolate molecules less than 30 kDa for use as
microglia-derived factors to treat primary neurons (Figure 2A).
Under control conditions, the mean number of AV in primary
control neurons was 119.367.4 (Figure 2B), likely representing the
constitutive autophagy activity necessary for neuronal survival. In
many cell types autophagy is induced as a starvation response,
activated to provide sources of energy. This induction occurs
through inhibition of the mammalian target of rapamycin
(mTOR), which negatively regulates the autophagy pathway in
cells, and can be mimicked by treatment with the mTOR inhibitor
rapamycin [30]. However, perhaps given the priority of the brain
in obtaining nutrients, autophagy is not strongly induced in CNS
neurons as part of the starvation response [31]. We found that
neurons treated for 24 hr with rapamycin exhibited a slight but
significant increase in AV number (Figures 2B and 2C,
139.266.8), indicating that autophagy can be pharmacologically
activated in our experimental model.
We next examined whether the supernatant from SIV-infected
microglia had an effect on the number of AV. Exposure resulted in
a significant reduction in the number of AV after 3 hr of exposure
(Figures 2B and 2C, 53.562.8), which remained low following
24 hr of exposure (Figures 2B and 2C, 48.662.5). Neurons treated
with supernatant from microglia cultured from uninfected
monkeys exhibited AV numbers indistinguishable statistically
from untreated controls (150621.6). The observed decrease in
AV content indicated either (i) the rate of AV degradation was
higher than the rate of AV formation, (ii) AV formation was
significantly inhibited, or (iii) the loss of neurites contribute to the
loss of AV. To help address this, we then determined whether
rapamycin could prevent the decrease of AV in neurons induced
by the microglia supernatant. Neurons were pretreated with
rapamycin followed by exposure to the supernatant for 24 hr,
resulting in complete protection from the decrease in number of
AV (Figures 2B and 2C, 15769.6). Taken together, these data
indicate that the supernatant from SIV-infected microglia
inhibited the induction of autophagy in primary neurons, and
this effect was reversible with rapamycin treatment.
Altered subcellular distribution of AV and loss of neurites
Next, we determined if the subcellular AV distribution was
altered after exposure to the microglia supernatant. By differen-
tiating the limit of the neuronal cell body from the processes, we
were able to quantify the distribution of AV in the cell body and in
the processes of individual neurons. As shown in Figure 3A, the
number of cellular AV decreased significantly in processes of
individual neurons after exposure to microglia supernatant for 3 or
24 hr (Figure 3A) whereas at the same time points the AV number
was unchanged in the soma of neurons (Figure 3B). These data
indicate that in addition to an inhibitory effect, the exposure of
neurons to SIV-infected microglia supernatant treatment altered
the subcellular distribution of AV. Rapamycin stimulation of
autophagy, under control conditions, did not alter the subcellular
distribution of AV (Figures 3A and 3B). Moreover, rapamycin
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prevented the alterations in distribution of AV between the soma
and neurites (Figures 3A and 3B).
We observed a dramatic reduction of AV number in the
processes of neurons exposed to the SIV-infected microglia
supernatant, therefore it was necessary to determine if process
integrity was compromised. We thus determined process length
and number of process branch points per cell from high-resolution
confocal z-stacks of neurons labeled with GFP-LC3. Three-
dimensional image analysis revealed that both the total process
length, as well as the number of branch points, was significantly
reduced in neurons treated with SIV-infected microglia superna-
tant after 3 or 24 hr (Figures 3C and 3D). Therefore the SIV
microglia supernatant triggered the loss of the neuronal processes,
and in the remaining neurites, there are decreased numbers of AV.
Biochemical markers of autophagy in neuronal cultures
exposed to SIV microglia supernatant
We further investigated the observed impairment of neuronal
autophagy by SIV-infected microglia supernatant by Western blot
detection of different parameters of autophagic activity. The
conversion of LC-I to LC3-II is correlated with the number of AV,
and can be assessed by immunoblotting [10,32,33]. A second
approach to examine potential impairment of autophagy is
measuring the protein level of the conjugate Atg12-Atg5 that
drives the elongation step of autophagy [8]. A third alternative
technique for identifying the inhibition of autophagy is measuring
p62 protein upregulation [16,34]. Its level therefore can be used as
an index of autophagic degradative capacity. We used all three of
these methods to examine the potential impairment of autophagy
induced by the SIV-infected microglia supernatant. Similar to
three dimensional imaging results (Figures 2 and 3), Western blot
detection of LC3 revealed a time-dependent decrease in LC3-II
levels, indicating that neuronal AV numbers were significantly
decreased in the presence of the SIV-infected microglia superna-
tant in a time-dependent manner (Figure 4A). Detection of the
Atg12-Atg5 conjugate, revealed a time-dependent decrease in
conjugate formation (Figure 4A), evidencing inhibition to
autophagy. Examination of p62 protein levels revealed a
significant increase after 24 hr exposure to the microglia
supernatant (Figure 4A). Importantly, rapamycin increased both
LC3-II and Atg5-Atg12 conjugate levels, in both control cells and
cells exposed to SIV-infected microglia supernatant (Figure 4A),
consistent with impairment of autophagy. Moreover, rapamycin
decreased p62 levels in neurons treated with SIV-infected
microglia supernatant to control levels. The optical density of
bands was measured using imageJ software and the associated
graphs were presented (Figures 4B–4D). Control supernatant from
uninfected monkeys did not affect the LC3-II level for 3 and 24 hr
exposure time (data not shown).
Figure 1. Confocal imaging and three-dimensional model reconstruction of neuron transfected with GFP-LC3. (A–J) Confocal images
of different z sections (0.2 mm of thickness) of a neuron transfected with GFP-LC3 (A–D) and all sections are flattened (E). Higher magnification images
of the area outlined in white are shown in the inserts (A–D). Different sections of images of transfected neuron with GFP-LC3 (green) merged with
DAPI (blue). Scale bar, 20 mm. (K–O) Three-dimensional reconstruction from serial sections using IMARIS software, cell body and process (K) and
higher magnification of the zoomed area outlined in white (K-I). Reconstructed 3D image of the same neuron using IMARIS, which evaluates AV
localization in the reconstructed 3D image (M–O). Enlarged areas of neuron revealed the presence of AV in soma and neurites (N–O).
doi:10.1371/journal.pone.0002906.g001
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TNF-a and glutamate are major pro-inflammatory and
excitotoxic factors associated with neuronal death in HAD patients
and are potential candidate neurotoxins present in the SIV-
infected microglia supernatant [21]. To assess whether these
agents can themselves affect autophagy, we studied, separately, the
effect of TNF-a and the excitotoxic glutamate agonist N-methyl-D-
aspartate acid (NMDA) on AV in neurons. The total AV number
decreased significantly in neurons exposed to either TNF-a or
NMDA (Figures 5A and 5D). Both molecules had their main effect
in by reducing the number of AV in neurites (Figures 5B and 5D)
whereas TNF-a led to a small but significant increase in AV in the
soma (Figures 5C and 5D).
Role of autophagy in neuronal survival
Both quantitative confocal microscopy and Western Blot analysis
indicated that SIV-infected microglia supernatant significantly
inhibited neuronal autophagy activity and this affect was reversed
by rapamycin. We then sought to determine whether these changes
in autophagy were involved in neuronal survival. Using the 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as-
say,wefound that neuronalsurvivaldecreasedsignificantlyafter 3 or
24 hr in the presence of the SIV-infected microglia supernatant
(Figure 6A, 91.161.1% and 68.961.1% of 100% baseline,
respectively). Rapamycin pretreatment conferred significant protec-
tion of the neurons against the neurotoxic effect of SIV-infected
microglia supernatant after 24 hr (Figure 6A, 86.261.9%), although
not recovering completely to the baseline level. Furthermore, pre-
treatment with (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-diben-
zo[a,d]cyclohepten-5,10-imine (MK-801), a non-competitive antag-
onist of the NMDA receptor, also abrogated neuronal cell death,
confirming the importance of the excitotoxic glutamate pathways
(Figure 6A). Data obtained from the lactate dehydrogenase (LDH)
release assay confirmed the neurotoxicity results of the MTT assay
(data not shown). These data strongly indicate that impaired
autophagy contributes to the neuronal damage, and enhancing
autophagy with rapamycin can inhibit a significant portion of
neurotoxic effect of SIV-infected microglia supernatant.
We then examined the effect of distinct stages of autophagy
inhibition on neuronal cell viability using chemical inhibitors.
Figure 2. In vitro analysis of the impact of SIV-infected microglia supernatant on autophagy in primary neurons. (A) Model of
experimental design, as detailed in the Materials and Methods. (B) Total AV counting results show that a significant drop in the number of AV occurs
in neurons exposed to SIV-infected microglia supernatant for 3 or 24 hr. Total number of AV are significantly increased after the pretreatment with
rapamycin followed by SIV-infected microglia supernatant (Sup) exposure for 24 hr. *** P,0.001, * P,0.05 for n=6 experiments. All values are
mean6SEM. AV counting using 3D model reconstruction for neurons exposed to different treatments. (C) Flattened images of multi-stack confocal
optical slices of neurons transfected with GFP-LC3 (green) to label AV, and DAPI (blue) to label the nucleus. The five panels display a typical sample
image of a neuron under control conditions as well as 3 hr and 24 hr exposure to SIV-infected microglia supernatant or pretreated with rapamycin
prior the exposure to SIV-infected microglia supernatant. The right hand panels show a snap shot of a 3D outline of the neuron with AV marked as
green spheres. Scale bar, 20 mm.
doi:10.1371/journal.pone.0002906.g002
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significantly in neurons exposed to the SIV-infected microglia supernatant for 3 or 24 hr, however; pretreatment with rapamycin blocked this effect.
*** P,0.001, for n=6 experiments. Scale bar, 20 mm. (B) The AV number is unchanged in neuronal soma after exposure to the SIV-infected microglia
supernatant for 3 or 24 hr. (C and D) Both the total length of neuronal processes (C) and number of brunch points (D) are decreased after exposure to
after SIV-infected microglia supernatant treatment. *** P,0.001, for n=6 experiments. All values are mean6SEM.
doi:10.1371/journal.pone.0002906.g003
Figure 4. Western blot analysis of autophagy related proteins. (A) The LC3-II level is reduced after 3 or 24 hr exposure to SIV-infected
microglia supernatant and this decrease effect is blocked when is pretreated with rapamycin (2 mM). The protein level of elongation complex Atg12-
Atg5 is also reduced, and again the effect is blocked in the presence of rapamycin. The protein level of p62 is increased for similar conditions with SIV-
infected microglia supernatant, and the increase is blocked in the presence of rapamycin. GAPDH protein was used in these experiments as the
loading control. One representative experiment of n=4 is shown. (B, C and D) Ratios between LC3-II, Atg12-Atg5, p62, respectively, normalized to
GAPDH. Data are reported as mean6SEM (n=4). *** P,0.001.
doi:10.1371/journal.pone.0002906.g004
Neuronal Autophagy Dysfunction
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lysosomes, Bafilomycin A1 (Baf), by itself reduced neuronal
survival (Figure 6B). Pretreatment with Baf prior to exposure to
the SIV-infected microglia supernatant resulted in additional
neuronal death, indicated that different processes maybe affected
by these two agents. In contrast, treatment of cells with the
inhibitor of type PI3K type III, 3-methyladenine (3-MA), reduced
neuronal survival. However, a pretreatment with 3-MA followed
by exposure to the SIV-infected microglia supernatant did not
reveal any additional neurotoxic effect (Figure 6B).
p62 expression in SIVE and HAD brains
It has been shown that the expression of p62 is involved in
protein aggregation of different neurodegenerative diseases and its
transcript is upregulated in response to pro-apoptotic conditions
[35]. Moreover examining changes in p62 expression, at both the
mRNA and protein levels, can be used as an index of autophagic
activity [36]. To examine p62 expression, we first assessed the level
of p62 mRNA in uninfected monkeys compared to those infected
with SIV but lacking SIVE, as well as those with SIVE.
Quantitative real time PCR analysis revealed a significant increase
of the p62 transcript level (Figure 7A), shown here in the frontal
lobe, in SIVE compared to both brains from uninfected animals or
those infected with SIV but without encephalitis. Assessment of
hippocampus, caudate and cerebellum in addition to the frontal
lobe indicates an approximate 2-fold increase in p62 mRNA levels
in SIVE compared to uninfected monkeys. We next examined the
p62 mRNA transcripts levels in human brain specimens affected
with HAD and we compared with those with non neurological
diseased subjects. We found a significant upregulation of mRNA
p62 level in HAD patients (3.2-fold increase) versus non
neurological diseased subjects demonstrating the translation of
the results from experimental animals to humans (Figures 7A and
7B). We next analyzed p62 immunoreactivity in brains of monkeys
with SIVE and humans with HAD. Distinct staining within the
neuronal soma and proximal portions of their processes, as well as
dot-like structures in the neuropil, were found in both SIVE and
HAD brains (Figure 7C). Analysis of ubiquitin antibody labeling in
Figure 5. AV counting and distribution for neurons exposed to different treatments. (A) Total AV counting results show that a significant
drop occurs in neurons exposed to TNF-a or NMDA for 3 or 24 hr. *** P,0.001, ** P,0.01 for n=6 experiments. All values are mean6SEM. (B and C)
Distribution of AV number in soma and neurites respectively. (B) The number of AV in neurites decreased significantly in neurons exposed to both
TNF-a or NMDA for 3 or 24 hr. *** P,0.001, for n=6 experiments. (C) The AV number in soma is increased in neurons after exposure to TNF-a for 3 or
24 hr, however it remained unaffected in neurons after exposure to NMDA. ** P,0.01 for n=6 experiments. (D) Flattened images of multi-stack
confocal optical slices of neurons transfected with GFP-LC3 (green) to label AV, and DAPI (blue) to label the nucleus. transfected with GFP-LC3 (green)
to label AV, and DAPI (blue) to label the nucleus. The four panels display a typical sample image of a neuron under 3 hr and 24 hr exposure to TNF-a
or NMDA at 25 ng/ml and 35 mM respectively. Scale bar, 20 mm.
doi:10.1371/journal.pone.0002906.g005
Neuronal Autophagy Dysfunction
PLoS ONE | www.plosone.org 6 August 2008 | Volume 3 | Issue 8 | e2906SIVE and HAD brains revealed a similar dot-like structures in
neurons and similar abnormal pattern of increased ubiquitin
immunoreactivity as was found for p62 (Figure 7C).
Discussion
Here, we examined whether glial-derived products affect
neuronal autophagy. The ensemble of imaging, biochemical and
survival results strongly support the compromise of autophagy by
the SIV-infected microglia supernatant. We discovered that
autophagy was inhibited by exposure to SIV-infected microglia
supernatant, and importantly, rapamycin treatment both en-
hanced autophagic activity and conferred significant protection to
treated neurons. Our results identify the role of autophagy as
protective in response to pro-death signaling by SIV-infected
microglia in primary neurons. Furthermore, SIV-infected monkey
and HAD brain tissues exhibited patterns of p62 immunoreactivity
which is compatible with impaired autophagy.
Indeed, using quantitative, high-resolution three-dimensional
fluorescence imaging, our experiments clearly showed that AV are
significantly altered in the presence of SIV-infected microglia
supernatant. Biochemical markers confirmed the imaging results.
First, we found that the total AV numbers in neurons are
decreased in the presence of the SIV-infected microglia superna-
tant, and associated with striking loss of AV number in neurites.
Rapamycin treatment completely prevented this change. Consis-
tent with these results, immunoblot experiments revealed that the
key AV lipidated-protein marker, LC3-II, is also decreased in the
presence of the SIV-infected microglia supernatant and the
decrease is reversed with a rapamycin treatment. Further analysis
showed that autophagy elongation step, which is represented by
the Atg12-Atg5 complex, is severely affected in neurons exposed to
the SIV-infected microglia supernatant. In addition, the accumu-
lation of the p62 protein is consistent with the inhibition of
autophagy in the presence of SIV-infected microglia supernatant.
Together these results demonstrate that in neurons exposed to
SIV-infected microglia supernatant, autophagy is inhibited likely
at the level of induction. Both TNF-a and glutamate, leading
candidates in the neuronal damage induced by CNS HIV
infection, had effects similar to that of the supernatant.
Within the neurons, we find that AV are lost from the neurites.
Interestingly, in neurons, microtubules facilitate AV transport, and
it has been found that there is a retrograde transport of AV in the
case of stress (Iwata et al., 2005). The decreased AV formation,
illustrated by the decline in LC3-II and Atg12-Atg5 levels, may
combine with a potential retrograde transport of AV from the
neurites, leading to the detrimental affect of the SIV-infected
microglia supernatant on neuronal autophagy. Whether the loss of
the neurites themselves is secondary to the loss of AV or reflective
of a distinct pathological mechanism requires further study.
There is convincing evidence to support the idea that autophagy
has a protective function in neurons and its dysregulation is
associated with distinct forms of neurodegeneration. Despite the
prevalence of HAD, the molecular mechanisms underlying
neurodegeneration remain poorly understood. Compounds re-
leased by HIV-infected macrophage/microglia in AIDS patients
activate neuronal apoptotic death, resulting in HAD [20,21].
Indeed in our experiments a decrease in neuronal survival
paralleled the deficits in autophagy. Furthermore, survival was
enhanced in the presence of rapamycin, which reversed the loss of
autophagy. Although some neuronal loss still occurred, the SIV-
infected microglia supernatant may trigger multiple pathways
leading to neuronal death, with the impairment to autophagy
constituting only one of the pathways. The mechanism by which
rapamycin, via the inhibition of the negative regulator of
autophagy, mTOR, rescues the deficit here is not known. We
hypothesize that rapamycin induces autophagy at initiation step to
eliminate the effect of SIV-infected microglia supernatant.
Indirect support for the autophagy defect in our experiments
residing at the induction stage comes from the lack of additive
effects of 3-MA in the presence of supernatant, in contrast to Baf,
which acts at a late stage in the autophagy process. Moreover,
pharmacological inhibition of autophagy, at early or late stages of
the process with either 3-MA or Baf, respectively, activated cell
death, reflecting the protective role for constitutive autophagy in
primary neurons.
There is a strong interdependent relationship between autoph-
agy and apoptosis [37]. While apoptosis is a synchronized process
leading to cell death, autophagy is considered both a mechanism
to protect from toxicity in stress conditions as well as a mediator of
Figure 6. Neuronal survival after exposure to SIV-infected
microglia supernatant in the presence of different autophagy
related drugs. (A). Neuronal survival tested by MTT. There are
significant decreases of neuronal survival after exposure to SIV-infected
microglia supernatant for 3 or 24 hr, which is significantly abrogated in
the presence of rapamycin. Rapamycin alone has no effect. MK-801
(100 mM) also prevented the neurotoxicity induced by SIV-infected
microglia supernatant. *** P,0.001, for n=6 experiments. (B) Neuronal
survival was examined with MTT in cultures exposed to SIV-infected
microglia supernatant for 24 hr and in the presence or absence of
different drugs such as 3-MA (1 mM) or Baf (100 nM). There is no
significant difference between cells exposed to SIV-infected microglia
supernatant and a pretreatment with 3-MA followed by exposure to
SIV-infected microglia supernatant. However, there is a significant
decrease of neuronal survival exposed to SIV-infected microglia
supernatant when cells are pretreated with Baf. The SIV-infected
microglia supernatant from no infected monkey (no Sup) doesn’t affect
neuronal survival and there is no significant difference with control
samples. All values are mean6SEM.
doi:10.1371/journal.pone.0002906.g006
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induce apoptosis [38], inhibition of autophagy can also induce
apoptosis [39]. Apoptosis is a major candidate process for
neuronal death in the setting of HAD [40], but additional studies
are needed to uncover the relationship between reduced neuronal
autophagy and apoptosis in this disorder.
Therapeutic strategies based on facilitating efficient autophagy
have shown promise in neurodegenerative disease models. In fact
provocative experiments utilizing inducers of autophagy reveal
that induction and activation of autophagy processing can cleanse
intracytosolic toxic molecules or different disease-associated
intracytosolic aggregate-prone proteins such as mutant Hunting-
ton and A53T a-synuclein [41–43]. Enhancing autophagy thus
has various beneficial consequences, not only promoting the
clearance of toxic aggregated proteins, but also protecting against
certain subsequent pro-apoptotic insults. For example, in response
to apoptotic stimuli, autophagy can remove potentially harmful
mitochondria and transiently increase protective ATP levels
[44,45]. Ubiquitin-protein aggregates are also cleared through
autophagy pathway and one of the characteristic of autophagy
malfunction is the increase of ubiquitinated proteins, as it has been
reported for different neurodegenerative diseases such as Alzhei-
mer’s, Parkinson’s, and Huntington’s diseases (AD, PD, and HD)
as well as the genetically deficient Atg5 and Atg7 knockout mice.
It has been found that the increased expression of p62
secondary to impaired autophagy may predispose to inclusion
formation [46]. Interestingly, it has recently been demonstrated
that ubiquitin-positive inclusions, which were otherwise abundant-
ly present in Atg7-deficient neurons, are markedly reduced by
genetic deletion of p62 [18]. In neurodegenerative diseases
increased p62 is a common feature detected in inclusion bodies
containing polyubiquitinated protein aggregates, including Lewy
bodies in PD, neurofibrillary tangles in AD, and Huntingtin
aggregates in HD [14,47,48]. The increased transcript level of p62
found here may suggest that it can be implicated in physiopa-
thology of protein aggregation and/or it is a natural response to
Figure 7. Transcriptional regulation of p62 in SIVE monkey brains, and its presence in human and monkey neurons associated with
ubiquitin. (A) Relative values (RV) of p62 mRNA level in frontal lobe of SIVE versus SIV and uninfected (UN) monkeys, n=7 for SIVE, n=12 for SIV and
n=9 for UN, P,0.05. (B) RV of p62 mRNA level in frontal cortex of HAD versus non neurological diseased subjects (NNDS), n=8 for HAD and n=10 for
NNDS, P,0.0001. (C) p62 and ubiquitin immunoreactivity on serial sections in SIVE monkeys, as well as those with HAD in brain sections from
hippocampus. p62 has a diffuse immunoreactivity in UN monkeys and in human NNDS and a dot profile structures in SIVE and HAD brain tissues.
Higher magnification views are shown in green insets. Black arrows indicate p62- or ubiquitin-immunoreactive structures within the neuronal cell
body or proximal processes, and red arrowheads indicate a dot-like immunoreactivity in the neuropil. Scale bar, 20 mm.
doi:10.1371/journal.pone.0002906.g007
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subjects. Decreased neuronal autophagy could lead to increased
p62 and ubiquitinated protein immunoreactivity within the
neurons/neuropil, as we saw in SIVE and HAD brains. This
result is further supported by reports of others of ubiquitin protein
deposits in neurons in those with HAD [27]. These findings are
consistent with recent report that the autophagic removal of
ubiquitinated protein aggregates is mediated by the interaction
between p62 and K63-linked polyubiquitin [49].
Here we clearly show that pathological glia can induce the
perturbation and decrease of autophagy in neurons, leading to
neuronal demise. Autophagy can be considered as the verve of
non-dividing cells such as neurons. Homeostasis of autophagy is be
a reliable security factor which needs to be maintained and
protected in neurons exposed to any insults, such as those leading
to neurodegeneration diseases, demonstrated here for the SIV
model of HAD.
Materials and Methods
Neuronal cultures, transfection and drug treatments
Primary neurons were cultured as previously described [50,51].
In brief, the cerebrocortices of Sprague-Dawley rat embryos at day
17 of gestation, were digested and plated on poly-DL-lysine (30–
70 kDa, Sigma-Aldrich, St. Louis, MO, USA) coated glass
coverslips at a density of 3610
5 cells/ml in high glucose
Dulbecco’s Minimum Essential Medium (DMEM) containing
GlutaMax
TM supplemented with 10% bovine calf serum, 25 mg/
ml penicillin/streptomycin. The cultures were incubated at 37uC
humid incubator for 60 min before switching to a neurobasal
medium containing 2% B27 (Invitrogen, Carlsbad, CA, USA).
Fluorodeoxyuridine (10 mM; Sigma-Aldrich) was added 1–3 days
after plating, and cells were fed twice weekly thereafter. All cells
were grown at 37uC and in 5% CO2. Most of the experiments
were performed on 16–20 days in vitro cultures unless otherwise
indicated. The purity of the neuronal population was verified by
immunocytochemical staining for MAP-2. Under these conditions,
the cultures were .98% homogeneous for neurons.
Cells on coverslips were transiently transfected at 12–17
divisions with 0.5 mg of GFP-LC3 plasmid DNA [10], using
Lipofectamine 2000 reagent (Invitrogen). Under these conditions,
,2% transfection efficiency was achieved in neurons and
experiments were performed after 2–5 days.
Transfected cells on coverslips, or cells grown on 24 well plates
for MTT and LDH assays, or 6 well plates for Western Blots, were
treated, for the indicated times, with supernatant from SIV-
infected at a final concentration of 1:20, or control uninfected,
microglia. For drug treatments, cells were treated with rapamycin
(2 mM, EMD Calbiochem, San Diego, CA), TNF-a (25 ng/ml,
PeproTech, Inc., Rocky Hill, NJ), NMDA (35 mM, Sigma-
Aldrich), MK-801 (100 mM, EMD Calbiochem) 3-methyladenine
(1 mM, Sigma-Aldrich), or Bafilomycin A1 (100 nM, Sigma-
Aldrich), for 30 minute prior exposure (or not) to the supernatant
from SIV-infected microglia.
Three dimensional confocal AV Counting Assay
Images were acquired using a Rainbow Radiance 2100 Laser
Scanning Confocal system attached to a Nikon TE2000-U
inverted microscope (BioRad-Carl Zeiss Inc., Thornwood, NY,
USA). All images were 8-bit optical slices and were obtained using
a6 0 6(1.4 N.A.) objective to capture the entire neuron (cell body
and processes) at the best resolution (0.2 mM interval step slices,
Figures 1A–1J). Images were acquired using Laser Sharp 2000
software then imported and further analyzed for detailed
quantitative 3D analysis using the IMARIS software package
(BitPlane Inc., MN, USA). Once imported into the IMARIS
software, the macro ‘‘filament tracker’’ was used to automatically
trace the GFP-LC3 fluorescence signal in 3D space to define the
spatial location of the cell body and all of its branches, dendrites
and axon (Figures 1K–1O), and thus create a 3D outline of the
neuron (macro designed for this purpose in IMARIS). For this
process, to outline and define the entire neuron, a larger and less
discriminating fluorescent threshold range was used (between 10–
256 shades/levels of grey), which includes specific labeling and
cytoplasmic haze that defines all the branches. Once this detailed
outline of the neuron was created (which has dimensions that are
based on the original signal), the software can extract parameters
such as neurites area and volume, number of free unassociated
termination points and number of branch points.
Alternatively, a very discriminating signal threshold range
(between 100 and 256) was used to define a real signal above
background for outlining and marking positively labeled vacuoles.
This range was used to define the GFP-LC3 vacuoles through out
the cell body and its branches (axon and dendrites). In addition,
we determined that the size of the smallest vacuole that can be
distinguished as a vacuole by the software successfully to have an
average diameter of 1 mm. The ‘‘spot tracker’’ tool in IMARIS
was then used to automatically track this thresholded signal range
and defined diameter per vacuole in 3D space and place a sphere
at the centroid of each bright signal spot that was deemed a
vacuole (macro designed for this purpose in IMARIS, see
Figure 1B). Once this was accomplished, the IMARIS software
calculated parameters such as the number detected, and their
fluorescent intensity and location. The data was then exported to
MS Excel and further analyzed for statistics and graphing. For the
various conditions described above at least 200 cells were used
over 8 experiments.
SIV-infected Microglia Supernatant Preparation
To mimic the indirect effect of HIV/SIV on neurons, we
prepared supernatants from microglia/macrophages derived from
the brains of SIV-infected and uninfected rhesus monkeys
(Figure 2A). All animal work was performed under NIH guidelines
with the approval of the TSRI Institutional Animal Care and Use
Committee. For monkey infections, a microglia-passaged stock of
SIVmac251 was used, denoted SIVmac182, obtained by 3
generations of in vivo serial passage [52,53]. Brains were obtained
from SIV-infected or uninfected monkeys following vascular
perfusion with PBS/heparin at necropsy. Tissue was disrupted,
digested with collagenase, and microglia/macrophages isolated by
a Percoll gradient technique [54]. Cells were plated in 6 well plates
at a density of 3610
6 cells/ml in RPMI 1640 containing
glutamine supplemented with 10% bovine calf serum, 25 mg/ml
penicillin/streptomycin, 50 ng/ml Macrophage Colony Stimulat-
ing Factor (PeproTech, Inc.) and cultured for up to 30 days.
Following the first 7 days of culture of cells from SIV-infected
animals, the supernatant was harvested daily, and the level of SIV
p27 Gag measured by ELISA kit. Those with p27 levels .1 ng/ml
were pooled and centrifuged through Centriplus filters (Millipore
Billerica, MA, molecular weight cutoff 30 kDa) and filtrates
(,30 kDa fractions) collected. The equivalent days post-plating
were collected from cultures derived from uninfected monkeys as
control supernatants.
Brain tissues
The National NeuroAIDS Tissue Consortium (Rockville, MD)
provided clinical diagnosis and post-mortem brain tissues from 8
individuals with HAD, and 10 individuals without HIV infection
Neuronal Autophagy Dysfunction
PLoS ONE | www.plosone.org 9 August 2008 | Volume 3 | Issue 8 | e2906and without any neurological symptoms or significant neuropa-
thology. Tissue from 7 uninfected rhesus monkeys and 8 with
SIVE were from our previous studies. All samples were obtained
under institutional regulatory approval following NIH guidelines.
Immunofluorescence statining
After different treatments, cells were fixed for 25 min with
ice-cold 4% paraformaldehyde (PFA) at 4uC and washed three
times in PBS, at room temperature. PFA-fixed cells were
permeabilized by using 0.2% Tween 20/PBS, and nonspecific
binding sites were blocked by incubation for 1 hr with a 10%
solution of heat-inactivated goat serum in 0.2% Tween 20/PBS.
To specifically stain neurons, cells were then incubated for
overnight at 4uC of anti-microtubule associated protein-2 (MAP-
2; Sigma-Aldrich) at 1:500. Cells were then incubated with
secondary polyclonal antibody, Rhodamine Red
TM-X conjugat-
ed goat anti-mouse IgG (Invitrogen) at 1:500 for 1 hr at room
temperature. Cells were counterstained with the fluorescent
nuclear stain 496-diamidino-2-phenylindole (DAPI; Sigma-Al-
drich) at 1 mg/ml, air-dried and mounted on glass microscope
slides in Vectashield mounting media (Vector Laboratories, CA,
USA).
Western Blot analysis
Following different treatments, neurons were washed one time in
ice-cold PBS, scraped, and lysed in ice-cold RIPA lysis buffer
[50 mM HEPES buffer, 1 mM sodium orthovandate, 10 mM
sodium pyrophosphate, 10 mM NaF, 1% NP-40, 30 mM p-
nitrophenyl phosphate (MP Biomedicals, Solon, OH, USA),
1m M P M S F , 1 6 complete protease inhibitor cocktail (Roche
Diagnostics, Indianapolis, IN, USA)]. After incubation for 30 min
on ice, samples were centrifuged at high speed for 25 min and
supernatants containing soluble proteins were collected. Total
protein concentration was determined with the bicinchoninic acid
assay, using bovine serum albumin as standard. Proteins were
separated on NuPAGE 12% (for LC3 antibody) or 4%–12% Bis-
Tris acrylamide gradient gels (Invitrogen) and transferred onto
electrophoretically to HY-bond
TM PVDF membranes (Invitrogen).
Nonspecific antibody binding was blocked by either 5% BSA or
nonfat dried milk for 1 hr at room temperature. Immunoblotting
was carried out with antibodies against LC3 (MBL International,
Woburn, MA, USA), Atg5 [8] and p62 (BD Transduction
Laboratories,SanDiego,CA,USA),followedbysecondaryantibody
(1:10,000 HRP conjugated anti rabbit or anti mouse IgG; GE
Healthcare, Little Chalfont, UK). Blots were developed with 1:1
solution of Super Signal West Pico Chemiluminescent Substrate and
Luminol/Enhancer (Thermo Fisher Scientific, Rockford, IL, USA).
Blots for loading control were stripped subsequently using ReStoreH
Western Blot stripping buffer (Thermo Fisher Scientific) then re-
probed for GAPDH (Millipore, Billerica, MA, USA). The optical
density of bands was quantitated using the ImageJ v.1.38 software
and the ratios to GAPDH were normalized for time 0 hr and then
expressed as fold- values of the mean6SEM.
Reverse Transcription and Quantitative Real Time PCR
Isolation of RNA and quantification of specific mRNAs by real-
time PCR in brain specimens was performed as described previously
[55]. For rhesus monkey and human p62, primers were CAGT-
CCCTACAGATGCCAGA and TCTGGGAGAGGGACTCAA-
TC, the double-labeled probe was TCCCAGGAGGGACCCA-
CAGG. The average of 18S, TATA box binding protein (TBP) and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) RNA were
used for macaques, and 18S and GAPDH for human, as the
endogenous controls using the primers/probe sets described [55].
Immunohistochemistry
Formalin-fixed, paraffin-embedded of serial brain sections were
cut at 6 mm thickness, mounted on glass slides, deparaffinized and
subjected to heat-mediated antigen retrieval (AR) with a steamer
for p62 and ubiquitin respectively. Indirect immunohistochemistry
was then performed as previously described [55]. Primary
antibodies were a mouse monoclonal antibody against p62 (BD
Transduction Laboratories), using pH 9 Tris-EDTA buffer for
AR, and rabbit polyclonal antibody against ubiquitin (Lab Vision
Corp., Thermo Fisher Scientific, Fremont, CA), using 0.01 M
citrate buffer, pH 6.39 for AR.
Neuronal Survival and Toxicity Assays
Cell survival and death were measured conjointly in 24-well
culture dishes 24 hr after the indicated treatments. Neurotoxicity
was monitored by the measurement of LDH activity released from
the cytosol of damaged cells into the supernatant. Culture medium
(200 ml/well) was sampled and centrifuged to remove cellular
debris from the supernatant in order to measure the LDH
enzymatic assay following the vendor’s kit manual (Roche Applied
Science, Indianapolis, IN). Triton X-100-treated (2%) cells were
used to determine the maximum releasable LDH activity in the
cells. The percentage of LDH release was calculated as LDH in
the culture medium divided by total LDH (maximum releasable
LDH activity). For the assay, LDH assay reagent was incubated
for 30 min at room temperature, and the absorbance of samples
was measured using a Victor3 Multilabel Counter (PerkinElmer,
Boston, MA), taking absorbance measurements at wavelength of
490 nm. The same plate was then used to monitor the
mitochondrial respiration using the reduction of MTT into a blue
formazan precipitate. For the MTT assay, neurons grown in 24-
well culture dishes were incubated with MTT (0.5 mg/ml) for
30 min at 37uC. The blue formazan produced was solubilized in
1 ml of dimethyl sulfoxide, and the amount of MTT formazan
product was determined by measuring immediately using a
Multilabel Counter 1420 Victor (PerkinElmer), taking absorbance
measurements at wavelength of 560 nm.
Statistical Analysis
Statistical analysis was carried out using GraphPad Instat. All
experiments were repeated at least six times, unless otherwise
stated. Results are shown as the mean6SEM. For two groups data
were evaluated by Student’s t-test, for more than two a one-way
analysis of variance (ANOVA) followed by post-hoc Tukey’s test was
used for multiple comparisons. Significance was assessed at
P,0.05.
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